CD83 and prostate neoplasm: Immunohistochemical analyses were performed to identify CD209+ (immature DC), CD83+ (mature DC), CD68+ (total MΦ) and CD163+ (M2-type MΦ) cells in the 99 prostate tumors (Figure 2).